The largest database of trusted experimental protocols

3 protocols using levofloxacin

1

Antimicrobial Susceptibility Testing Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
Minimum inhibitory concentrations (MICs) were determined using the agar doubling-dilution
method, in accordance with the criteria proposed by the Clinical and Laboratory Standards
Institute (CLSI) [5 ]. The following antimicrobial
agents were used: ampicillin (FUJIFILM Wako Pure Chemical Corp., Osaka, Japan), oxacillin
(Sigma-Aldrich, St. Louis, MO, USA), cephalexin (Tokyo Chemical Industry Co., Ltd., Tokyo,
Japan), imipenem (FUJIFILM Wako), fosfomycin (Sigma-Aldrich), enrofloxacin (Tokyo Chemical
Industry), levofloxacin (FUJIFILM Wako), erythromycin (Sigma-Aldrich), lincomycin
(Sigma-Aldrich), gentamicin (FUJIFILM Wako), minocycline (FUJIFILM Wako), chloramphenicol
(FUJIFILM Wako), and vancomycin (FUJIFILM Wako). The breakpoints of these antimicrobial
agents were determined using the interpretation criteria proposed by the CLSI [6 ].
+ Open protocol
+ Expand
2

Antibiotic Susceptibility Testing of H. pylori

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibiotic susceptibility was detected using a serial two-fold agar dilution assay to determine the minimum inhibitory concentrations (MICs) of amoxicillin, clarithromycin, metronidazole, levofloxacin, and minocycline (Wako Pure Chemical Industry, Osaka, Japan) according to the guidelines of the Clinical and Laboratory Standards Institute (CLSI) (Wayne, PA, USA). Briefly, bacteria were subcultured on Mueller-Hinton II Agar medium (Becton Dickinson, Sparks, MD, USA) supplemented with 5% defibrinated horse blood. The bacterial suspension was adjusted to OD600 = 0.1, and a 48-pin inoculator was used to inoculate the culture plate (1 μL per spot, approximately 104 colony forming units [CFU] of bacteria). H. pylori strain 26695 was used as a control strain. MICs were judged according to the presence or absence of growth at the spots at the lowest concentration of antibiotic, followed by checking growth at the spots using 1:1 dilutions after 72-h incubation. Resistance or sensitivity to antibiotics was judged according to the guidelines of the European Committee on Antimicrobial Susceptibility Testing (EUCAST; http://www.eucast.org/). The clinical breakpoints of MICs indicating antibiotic resistance are >0.125 mg/L, amoxicillin; >0.5 mg/L, clarithromycin; >8 mg/L, metronidazole; >1 mg/L, levofloxacin; and >1 mg/L, minocycline. Duplicate agar dilution assays were repeated 2–3 times.
+ Open protocol
+ Expand
3

Antibiotic-Susceptible P. aeruginosa Isolates

Check if the same lab product or an alternative is used in the 5 most similar protocols
A total 413 clinical isolates of P. aeruginosa were collected from 16 general hospitals in the Tohoku district, Japan. Twenty clinical isolates which showed susceptibility to six anti-pseudomonal agents; piperacillin, levofloxacin, tazobactam/piperacillin, meropenem, ceftazidime and amikacin, and also their viability to survive against 1 mM H 2 O 2 , used as a ROS, were selected. The specimen origins of these strains are as follows: sputum (35%), urine (30%), pharynx (10%), and others (25%) (Table 1).
Powders of piperacillin (Taisho-Toyama Pharmaceutical Co., Ltd., Tokyo), levofloxacin (Wako, Osaka), amikacin (Wako), ceftazidime (Wako), meropenem (Sumitomo Dainippon Pharma Co. Ltd., Osaka), and tazobactam (Sigma-aldrich, Darmstadt, Germany) were used in this study. An a-lipoic acid derivative, sodium zinc histidine dithiooctamide (DHL-His-Zn) (Fig. 1) was used as anti-ROS agent [9e12]. Efflux pump inhibitors, carbonyl cyanide m-chlorophenyl hydrazone (CCCP: Wako) and phenylalanine-arginine-b-naphthylamide (PabN: Sigma-aldrich) were also prepared.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!